These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 35253634)
1. Molecular Docking and Dynamics Simulation of Natural Phenolic Compounds with GSK-3β: A Putative Target to Combat Mortality in Patients with COVID-19. Khamverdi Z; Mohamadi Z; Taherkhani A Recent Adv Inflamm Allergy Drug Discov; 2022; 15(1):16-34. PubMed ID: 35253634 [TBL] [Abstract][Full Text] [Related]
2. Receptor-based pharmacophore modeling, virtual screening, and molecular docking studies for the discovery of novel GSK-3β inhibitors. El Kerdawy AM; Osman AA; Zaater MA J Mol Model; 2019 May; 25(6):171. PubMed ID: 31129879 [TBL] [Abstract][Full Text] [Related]
3. Computational Investigation of Novel Compounds as Dual Inhibitors of AChE and GSK-3β for the Treatment of Alzheimer's Disease. Londhe SG; Shenoy M; Kini SG; Walhekar V; Kumar D Curr Top Med Chem; 2024; 24(19):1738-1753. PubMed ID: 38859777 [TBL] [Abstract][Full Text] [Related]
4. Docking, molecular dynamics, binding energy-MM-PBSA studies of naphthofuran derivatives to identify potential dual inhibitors against BACE-1 and GSK-3β. Kumar A; Srivastava G; Negi AS; Sharma A J Biomol Struct Dyn; 2019 Feb; 37(2):275-290. PubMed ID: 29310523 [TBL] [Abstract][Full Text] [Related]
5. Screening of potential drug for Alzheimer's disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation. Elangovan ND; Dhanabalan AK; Gunasekaran K; Kandimalla R; Sankarganesh D J Biomol Struct Dyn; 2021 Nov; 39(18):7065-7079. PubMed ID: 32779973 [TBL] [Abstract][Full Text] [Related]
7. Biological evaluation and energetic analyses of novel GSK-3β inhibitors. Zhang D; Liu L; Pang L; Jin Q; Ke K; Hu M; Yang J; Ma W; Xie H; Chen X J Cell Biochem; 2018 Apr; 119(4):3510-3518. PubMed ID: 29144001 [TBL] [Abstract][Full Text] [Related]
8. Prediction of binding affinity of 1,2-diphenyline ketone analogues at adenosine triphosphate binding site of glycogen synthase kinase-3β: a molecular docking and dynamic simulation study. Dinakar S; Gurubarath M; Dhananjayan K J Biomol Struct Dyn; 2023 Jul; 41(11):4847-4862. PubMed ID: 35543239 [TBL] [Abstract][Full Text] [Related]
9. Investigation of naphthofuran moiety as potential dual inhibitor against BACE-1 and GSK-3β: molecular dynamics simulations, binding energy, and network analysis to identify first-in-class dual inhibitors against Alzheimer's disease. Kumar A; Srivastava G; Srivastava S; Verma S; Negi AS; Sharma A J Mol Model; 2017 Aug; 23(8):239. PubMed ID: 28741112 [TBL] [Abstract][Full Text] [Related]
10. Pharmacophore-Based Screening, Molecular Docking, and Dynamic Simulation of Fungal Metabolites as Inhibitors of Multi-Targets in Neurodegenerative Disorders. Iqbal D; Alsaweed M; Jamal QMS; Asad MR; Rizvi SMD; Rizvi MR; Albadrani HM; Hamed M; Jahan S; Alyenbaawi H Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002295 [TBL] [Abstract][Full Text] [Related]
11. COVID-19: docking-based virtual screening and molecular dynamics study to identify potential SARS-CoV-2 spike protein inhibitors from plant-based phenolic compounds. Moradkhani S; Farmani A; Saidijam M; Taherkhani A Acta Virol; 2021; 65(3):288-302. PubMed ID: 34565157 [TBL] [Abstract][Full Text] [Related]
12. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor. Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749 [TBL] [Abstract][Full Text] [Related]
13. E-pharmacophore-based virtual screening to identify GSK-3β inhibitors. Natarajan P; Priyadarshini V; Pradhan D; Manne M; Swargam S; Kanipakam H; Bhuma V; Amineni U J Recept Signal Transduct Res; 2016 Oct; 36(5):445-58. PubMed ID: 27305963 [TBL] [Abstract][Full Text] [Related]
14. Rosmarinic Acid Derivatives' Inhibition of Glycogen Synthase Kinase-3β Is the Pharmacological Basis of Kangen-Karyu in Alzheimer's Disease. Paudel P; Seong SH; Zhou Y; Park CH; Yokozawa T; Jung HA; Choi JS Molecules; 2018 Nov; 23(11):. PubMed ID: 30413117 [TBL] [Abstract][Full Text] [Related]
15. Discovery of novel and highly potential inhibitors of glycogen synthase kinase 3-beta (GSK-3β) through structure-based pharmacophore modeling, virtual computational screening, docking and in silico ADMET analysis. Benghanem S; Mesli F; Fatima Zohra HA; Nacereddine C; Hadjer C; Abdellatif M J Biomol Struct Dyn; 2024 Sep; 42(14):7091-7106. PubMed ID: 37498130 [TBL] [Abstract][Full Text] [Related]
17. (Z)-2-(3-Chlorobenzylidene)-3,4-dihydro-N-(2-methoxyethyl)-3-oxo-2H-benzo[b][1,4]oxazine-6-carboxamide as GSK-3β inhibitor: Identification by virtual screening and its validation in enzyme- and cell-based assay. Joshi P; Gupta M; Vishwakarma RA; Kumar A; Bharate SB Chem Biol Drug Des; 2017 Jun; 89(6):964-971. PubMed ID: 27896926 [TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis and Biological Evaluation of 7-Chloro-9 Andreev S; Pantsar T; Ansideri F; Kudolo M; Forster M; Schollmeyer D; Laufer SA; Koch P Molecules; 2019 Jun; 24(12):. PubMed ID: 31242571 [TBL] [Abstract][Full Text] [Related]
19. Computational and ADMET Predictions of Novel Compounds as Dual Inhibitors of BuChE and GSK-3β to Combat Alzheimer's Disease. Londhe SG; Walhekar V; Shenoy M; Kini SG; Scotti MT; Scotti L; Kumar D Pharmaceutics; 2024 Jul; 16(8):. PubMed ID: 39204336 [TBL] [Abstract][Full Text] [Related]
20. Discovery of Novel Imidazopyridine GSK-3β Inhibitors Supported by Computational Approaches. Buonfiglio R; Prati F; Bischetti M; Cavarischia C; Furlotti G; Ombrato R Molecules; 2020 May; 25(9):. PubMed ID: 32380735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]